Jr Walden Philip Loberg

Evp, Interim Cfo at Valeant Pharmaceuticals International Inc. (VRX), 2011-07-27

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
VRX	$52.82	7,500	$396,150.00	137,565	2011-06-09	Filing